Ultragenyx Pharmaceutical Inc. (RARE) Insider Trading

Name: Ultragenyx Pharmaceutical Inc. (RARE) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 15, 2026): Huizenga Theodore Alan (SVP, Chief Accounting Officer): Sale of 1,283 shares, $17.4K.

Get alerted when insiders trade RARE

Email address

Loading company data...

Loading company details...